-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
Humana's Income Statement
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$83.06 B | $92.87 B | $106.37 B | $117.76 B | $129.66 B |
| Cost of Revenue |
|
- | - | - | - | $110.81 B |
| Gross Profit |
|
$83.06 B | $92.87 B | $106.37 B | $117.76 B | $18.85 B |
| Research & Development |
|
- | - | - | - | - |
| Selling,General & Administrative |
|
- | - | - | - | - |
| Operating Expense |
|
$79.71 B | $89.30 B | $102.99 B | $116.04 B | $17.40 B |
| Operating Income |
|
$3.35 B | $3.57 B | $3.38 B | $1.72 B | $1.45 B |
| Net Income |
|
$2.93 B | $2.81 B | $2.49 B | $1.21 B | $1.19 B |
Humana's Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$4.67 B | $3.39 B | $5.06 B | $21.32 B | $20.44 B |
| Inventories |
|
- | - | - | - | - |
| Total Current Assets |
|
$4.67 B | $3.39 B | $5.06 B | $29.99 B | $29.82 B |
| Property,Plant and Equipment |
|
$2.81 B | $3.75 B | $3.74 B | $3.54 B | $2.53 B |
| Goodwill |
|
$4.45 B | $11.09 B | $9.14 B | $9.55 B | $9.63 B |
| Total Assets |
|
$34.97 B | $44.36 B | $43.06 B | $47.07 B | $46.48 B |
| Total Liabilities |
|
$21.24 B | $28.26 B | $27.69 B | $30.75 B | $30.03 B |
| Retained Earnings |
|
$20.52 B | $23.09 B | $25.49 B | $27.54 B | $28.32 B |
| Total Shareholder Equity |
|
$13.73 B | $16.08 B | $15.31 B | $16.26 B | $16.38 B |
| Common Stock |
|
$33.00 M | $33.00 M | $33.00 M | $33.00 M | $33.00 M |
Humana's Cash flow
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$713.00 M | $845.00 M | $917.00 M | $968.00 M | $773.00 M |
| Dividends Payout |
|
-$354.00 M | -$392.00 M | -$431.00 M | -$431.00 M | -$430.00 M |
| Capital Expenditures (Capex) |
|
-$1.32 B | -$1.12 B | -$1.00 B | -$575.00 M | -$546.00 M |
| Free Cash Flow (FCF) |
|
$946.00 M | $3.47 B | $2.98 B | $2.39 B | $375.00 M |
Humana's Profitability
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$83.06 B | $92.87 B | $106.37 B | $117.76 B | $18.85 B |
| Gross Profit Margin (%) |
|
100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Operating Income |
|
$3.35 B | $3.57 B | $3.38 B | $1.72 B | $1.45 B |
| Operating Income Margin (%) |
|
4.04% | 3.84% | 3.18% | 1.46% | 2.09% |
| Net Income |
|
$2.93 B | $2.81 B | $2.49 B | $1.21 B | $1.19 B |
| Net Income Margin (%) |
|
3.53% | 3.02% | 2.34% | 1.02% | 0.92% |
| EBITDA |
|
$4.39 B | $4.81 B | $4.79 B | $3.35 B | $2.91 B |
| EBITDA Margin (%) |
|
5.29% | 5.18% | 4.51% | 2.84% | 2.13% |
Humana's Ratios
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
18.24% | 18.33% | 15.31% | 7.37% | - |
| Return on Assets (ROA) |
|
6.61% | 6.52% | 5.29% | 2.60% | - |
| Debt to Equity |
|
65.55% | 59.00% | 62.80% | 68.05% | - |
| Debt to total asset |
|
23.76% | 20.98% | 21.70% | 23.98% | - |
| Enterprise value to revenue |
|
0.83 | 0.76 | 0.60 | 0.34 | 0.00 |
| Enterprise value to EBITDA |
|
15.66 | 14.71 | 13.28 | 11.97 | 0.00 |
| Enterprise value |
|
$68.79 B | $70.82 B | $63.67 B | $40.09 B | - |
| Tax Rate (%) |
|
14.19% | 21.38% | 25.18% | 25.38% | 16.08% |
Frequently Asked Questions
